Masimo Corporation (LON:0JZ2)
144.98
+4.43 (3.15%)
At close: Nov 7, 2025
Masimo Revenue
Masimo had revenue of $371.50M USD in the quarter ending September 27, 2025, with 8.21% growth. This brings the company's revenue in the last twelve months to $2.18B, up 38.48% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.
Revenue (ttm)
$2.18B
Revenue Growth
+38.48%
P/S Ratio
3.59
Revenue / Employee
$606.11K
Employees
3,600
Market Cap
5.84B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
| Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
| Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
| Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
| Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Masimo News
- 16 days ago - $1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today - Benzinga
- 17 days ago - Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 19 days ago - Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4 - Business Wire
- 23 days ago - Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock - Benzinga
- 4 weeks ago - Masimo to Host Investor Day on December 3, 2025 - Business Wire
- 4 weeks ago - In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones - Business Wire
- 5 weeks ago - Why Masimo (MASI) is a Top Growth Stock for the Long-Term - Nasdaq
- 5 weeks ago - Is the Options Market Predicting a Spike in Masimo Stock? - Nasdaq